PAK1 Expression in Pancreatic Cancer: Clinicopathological Characteristics and Prognostic Significance.

Nikolaos G SymeonidisMaria LambropoulouEfstathios PavlidisConstantinos AnagnostopoulosAlexandra TsarouchaAthanasia KotiniChristina NikolaidouAnastasia KiziridouConstantinos Simopoulos

Published in: Clinical Medicine Insights. Oncology (2019)

Our results indicate that PAK1 could potentially be used as a prognostic marker in pancreatic cancer. Further studies could clarify whether utilization of PAK1 in therapeutic protocols for the treatment of pancreatic cancer will render them more effective.

Keyphrases

poor prognosis
binding protein
long non coding rna
case control
smoking cessation